Insider Transactions in Q4 2022 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 21
2022
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
341
-0.11%
|
$3,069
$9.67 P/Share
|
|
Oct 13
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,793
-0.28%
|
$25,137
$9.18 P/Share
|
|
Oct 13
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
928
-0.24%
|
$8,352
$9.18 P/Share
|
|
Oct 11
2022
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-4.38%
|
$112,500
$9.44 P/Share
|
|
Oct 06
2022
|
Roivant Sciences Ltd. |
BUY
Open market or private purchase
|
Direct |
416,667
+0.56%
|
$2,500,002
$6.0 P/Share
|